- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05740839
Ejercicio de intervalos de alta intensidad en adultos jóvenes sobrevivientes de tumores cerebrales pediátricos: un estudio piloto de factibilidad (HYPE)
Ejercicio de intervalos de alta intensidad en adultos jóvenes sobrevivientes de tumores cerebrales pediátricos: un estudio piloto de viabilidad (HYPE)
The purpose of this study is to determine whether a 16-week virtual, home-based, high-intensity interval training (HIIT) exercise program will improve physical, cognitive, and emotional health among young adult survivors of pediatric brain tumors.
The names of the study interventions involved in this study are/is:
- High-Intensity Interval Training (HIIT)
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This is a Pilot/Feasibility, randomized control, research study that will compare an exercise group to a control group on physical, social, and overall quality of life needs of pediatric brain tumor survivors who are now young adults.
Participants will be randomized (selected at random) for two groups: HIIT program group will complete a 16-week intervention period followed by a 16-week period with no intervention and the waitlisted control group will complete a 16-week period and will perform their usual, daily activities followed by an optional 16-week period in which they can complete the HIIT program.
Research procedures include screening for eligibility, study treatment including in-clinic evaluations of fitness and strength, blood collection, at-home zoom exercise sessions, self-administered activity logs, and survey questionnaires.
Participation in this research study is expected to last about 8 months.
It is expected that about 30 people will take part in this research study.
The Stahl Family Charitable Foundation, Pedal 4 Pediatrics, and the Childhood Brain Tumor Foundation are supporting this research study by providing funding for the study.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Christina Dieli-Conwright, PhD, MPH
- Número de teléfono: 617-582-8321
- Correo electrónico: ChristinaM_Dieli-Conwright@dfci.harvard.edu
Ubicaciones de estudio
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02215
- Reclutamiento
- Dana Farber Cancer Institute
-
Contacto:
- Christina M Dieli-Conwright, PhD, MPH
- Número de teléfono: 617-632-3800
- Correo electrónico: ChristinaM_Dieli-Conwright@dfci.harvard.edu
-
Investigador principal:
- Christina M Dieli-Conwright, PhD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Written informed consent prior to any study-related procedures.
- At time of study are a young adult, aged 18-45 years.
- Histologically diagnosed brain tumor during childhood, or currently diagnosed with an IDH-mutant glioma (diagnosed > 18 years).
- Are at least 2 years post tumor-directed therapy for pediatric brain tumor survivors, or at least 1 year since their most recent surgery, radiation or chemotherapy treatment for IDH-mutant glioma patients (or are deemed able to participate in the study based on the assessment of their treating physician). IDH-mutant glioma patients can participate while on maintenance therapy with an IDH inhibitor.
- The effects of exercise on the developing fetus are unknown. For this reason, people of child-bearing potential must verify pregnancy status by providing first day of their last menstrual cycle and agree to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry. Should a person become pregnant or suspect that they are pregnant while participating on the trial, they should inform their treating physician immediately.
- Medically cleared to participate in exercise by their referring physician or a certified clinical exercise physiologist.
- If participants have a diagnosis of tumor-related epilepsy, they must have good seizure control, with no generalized seizures in the 6 months preceding enrollment.
- Are without any other medical conditions that could exacerbate with exercise, such as bone disease (excluding bone metastases) at imminent risk of fracture or uncontrolled cardiopulmonary or metabolic diseases.
- Speak English and/or Spanish.
- Currently participate in less than or equal to 60 minutes of moderate or vigorous structured exercise/week.
- Does not smoke cigarettes or e-cigarettes (no smoking during the previous 12 months). Those who infrequently smoke in social settings will be included. Those who vape will also be included.
- Willing to travel to DFCI for necessary data collection.
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- Diagnosis of primary spinal cord tumor.
- Pre-existing medical conditions such as uncontrolled tumor-related epilepsy, cardiopulmonary disease, or metabolic diseases that could exacerbate with exercise.
- Patients with evidence of progressive CNS or systemic cancer in the last 3 months.
- People who are pregnant, or plan to become pregnant during study duration will be excluded due to the unknown nature of exercise on developing fetuses.
- Actively on a weight loss diet.
- Participate in more than 60 minutes of moderate or vigorous structured exercise/week.
- Currently and regularly smokes.
- Unable to travel to DFCI for necessary data collection.
- May not be able to comply with the safety monitoring requirements of the study in the opinion of the investigator.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: HIIT Exercise Program Group
Participants will be randomly assigned to the HIIT exercise group and receive:
|
Exercise program with stationary bike via the Zoom platform.
Otros nombres:
|
|
Comparador activo: Control Group
Participants will be randomly assigned to the HIIT waitlist control group and receive:
|
Usual Activities |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Attendance of Exercise Sessions
Periodo de tiempo: From first exercise session to final exercise session, up to 16 weeks
|
Defined as participant attendance of >= 70% of the 48 HIIT exercise sessions. |
From first exercise session to final exercise session, up to 16 weeks
|
|
Completion in Minutes of Exercise Sessions
Periodo de tiempo: From first exercise session to final exercise session, up to 16 weeks
|
Defined as participant completion of >= 70% of the 90 minutes of exercise per week |
From first exercise session to final exercise session, up to 16 weeks
|
|
HIIT Compliance
Periodo de tiempo: From first exercise session to final exercise session, up to 16 weeks
|
Defined as obtaining +-5W of target power output for >= 40 seconds of high intensity minute |
From first exercise session to final exercise session, up to 16 weeks
|
|
Barriers to Exercise Adherence
Periodo de tiempo: From first exercise session to final exercise session, up to 16 weeks
|
Assessed through the 17-item Barriers to Recruitment Participation Questionnaire (BRPQ), 1-5 scale with 1 denoted as strongly agree and 5 as strongly disagree. |
From first exercise session to final exercise session, up to 16 weeks
|
|
Participant Burden
Periodo de tiempo: From first exercise session to final exercise session, up to 16 weeks
|
Assessed through the Perceived Research Burden Assessment (PRBA), 1-5 scale with 1 denoted as strongly disagree and 5 as strongly agree. |
From first exercise session to final exercise session, up to 16 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Cognition
Periodo de tiempo: : From baseline to post-intervention, up to 43 weeks
|
An assortment of tests will be executed through the NIH toolbox to measure overall cognition. |
: From baseline to post-intervention, up to 43 weeks
|
|
Cardiorespiratory Fitness
Periodo de tiempo: From baseline to post-intervention, up to 43 weeks
|
Assessed through the use of a VO2 max (or submaximal if equipment is unavailable) cycle exercise stress test (Parvo Medics TrueOne 2400; Sandy, UT, USA). |
From baseline to post-intervention, up to 43 weeks
|
|
Muscular Strength
Periodo de tiempo: From baseline to post-intervention, up to 43 weeks
|
10-repetition maximum will be used to assess muscular strength. |
From baseline to post-intervention, up to 43 weeks
|
|
Body Composition
Periodo de tiempo: From baseline to post-intervention, up to 43 weeks
|
Bioelectrical Impedance Analysis (BIA), and blood pressure as measured twice on both arms with a seated position with a minimum of 1-minute interval and the higher pressure will be recorded when there are differences. BIA: Assessed via bioelectrical impedance using a validated device (Tanita 780, Arlington Heights, IL). Participants will be asked to remove their shoes and socks after which height will be taken using a stadiometer they will then proceed to move to the BIA and stand still on the device while holding the handles with their hands at their sides. The device will estimate body fat using an algorithm based on their age, sex, height, and body weight. |
From baseline to post-intervention, up to 43 weeks
|
|
Fatigue
Periodo de tiempo: From baseline to post-intervention, up to 43 weeks
|
BFI: A questionnaire of scale ratings 0 - 10 that focuses on cancer-related fatigue and tiredness. |
From baseline to post-intervention, up to 43 weeks
|
|
Psychosocial Health
Periodo de tiempo: From baseline to post-intervention, up to 43 weeks
|
Assessed through the Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire, which is comprised of 27 items with scale ratings validated to measure physical, emotional, social, and functional well-being of cancer patients and survivors |
From baseline to post-intervention, up to 43 weeks
|
|
Quality of Sleep
Periodo de tiempo: From baseline to post-intervention, up to 43 weeks
|
Assessed through the Pittsburg Sleep Quality Index (PSQI), which is used to measure 7 components of the quality and patterns of sleep in participants. |
From baseline to post-intervention, up to 43 weeks
|
|
Dietary Assessment, ASA-24
Periodo de tiempo: Up to 3 days
|
Participants will be provided with a login to enter dietary data measured by an automated, online self-administered 24-hour assessment tool. |
Up to 3 days
|
|
ActiGraph - Physical Activity Monitoring
Periodo de tiempo: From baseline to post-intervention, up to 27 weeks
|
Participants will be provided with an accelerometer (ActiGraph, Pensacola, FL) to wear for seven days at baseline and post-intervention testing visits and will be instructed to wear the water-resistant accelerometer at all times except for when swimming or bathing. The device will record activity data and will be electronically transferred to a computer via USB cable at time of completion. |
From baseline to post-intervention, up to 27 weeks
|
|
Exercise Tolerance
Periodo de tiempo: From baseline to week 16, up to 32 weeks
|
Will be recorded using the Exercise-Induced Feeling Inventory (EIF). Based on a 0-4 scale, it assesses the participant's feeling state change(s) post-exercise and is also used for the assessment of self-motivation to adhere to an exercise regimen. Participants will be asked to complete the inventory before and after each exercise session. |
From baseline to week 16, up to 32 weeks
|
|
Pain Index
Periodo de tiempo: From baseline to post-intervention, up to 43 weeks
|
BPI: A 9 item questionnaire to evaluate the severity of pain and the impact of pain on the participant's daily functioning. |
From baseline to post-intervention, up to 43 weeks
|
|
Hip and Waist Circumference
Periodo de tiempo: From baseline to post-intervention, up to 43 weeks
|
Hip and waist circumference will be assessed and recorded in cm. |
From baseline to post-intervention, up to 43 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Christina Dieli-Conwright, PhD, MPH, Dana-Farber Cancer Institute
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Actividad motora
- Movimiento
- Fenómenos fisiológicos musculoesqueléticos
- Fenómenos fisiológicos musculoesqueléticos y neuronales
- Técnicas de investigación
- Diseño de investigación epidemiológica
- Métodos epidemiológicos
- Diseño de la investigación
- Métodos
- Acondicionamiento físico, humano
- Ejercicio
- Grupos de control
- Entrenamiento de intervalos de alta intensidad
Otros números de identificación del estudio
- 22-505
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: [contact information for Sponsor Investigator or designee]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.
Marco de tiempo para compartir IPD
Data can be shared no earlier than 1 year following the date of publication
Criterios de acceso compartido de IPD
Contact the Belfer Office for Dana-Farber Innovations (BODFI) at innovation@dfci.harvard.edu
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .